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Abstract
The genome of the protozoan parasite Toxoplasma gondii was found to contain two genes encoding tyrosine hydroxylase;
that produces L-DOPA. The encoded enzymes metabolize phenylalanine as well as tyrosine with substrate preference for
tyrosine. Thus the enzymes catabolize phenylalanine to tyrosine and tyrosine to L-DOPA. The catalytic domain descriptive of
this class of enzymes is conserved with the parasite enzyme and exhibits similar kinetic properties to metazoan tyrosine
hydroxylases, but contains a unique N-terminal extension with a signal sequence motif. One of the genes, TgAaaH1, is
constitutively expressed while the other gene, TgAaaH2, is induced during formation of the bradyzoites of the cyst stages of
the life cycle. This is the first description of an aromatic amino acid hydroxylase in an apicomplexan parasite. Extensive
searching of apicomplexan genome sequences revealed an ortholog in Neospora caninum but not in Eimeria,
Cryptosporidium, Theileria,o rPlasmodium. Possible role(s) of these bi-functional enzymes during host infection are
discussed.
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Introduction
Toxoplasma gondii is among the most successful of parasites with
the potential to infect all warm blooded animals and with an
estimated prevalence of 30% in the world’s human population
(1,2). Infection normally consists of an acute stage in which the
rapidly growing tachyzoites infect a range of tissues, followed by a
latent stage during which slowly replicating bradyzoites form tissue
cysts in muscle and brain (3,4). The tropism of parasites for brain
tissue is intriguing and has been linked with specific behavioural
changes. In rodents infection with T. gondii has been shown to
modify aversion to predators that might facilitate transmission of
parasites (5,6). There are also reports indicating infection may lead
to psychological sequelae in humans. The mechanism responsible
for the behavioural changes remains unclear.
As an intracellular parasite Toxoplasma is known to remodel
host cellular processes to supply the nutrients required for parasite
growth, protect against host defences, and facilitate replication and
transmission. During invasion and formation of the parasitophor-
ous vacuole, the parasite modifies the host cytoskeleton through
reorganization of intermediate filaments and capture of microtu-
bule organization centers and forms associations with mitochon-
dria and ER. The complement of host proteins changes during
tachyzoite infection with the induction of numerous mitochondrial
and several ER proteins (9–11). Subversion of the host cell
modifies transcription (e.g. ROP16 modulating STAT), blocks
apoptosis (e.g. NF-kappaB, caspases) and ensures supply of
essential nutrients (e.g. purines, polyamines, and cholesterol). T.
gondii relies on a combination of synthesis and salvage for supply of
the various amino acids. For example the parasites are
auxotrophic for tryptophan and arginine (12–14).
In the current study, we screened the T. gondii genome using
metabolic pathway reconstruction software (15–17) to identify
potentially secreted enzymes. This led to the unexpected
identification of an aromatic amino acid hydroxylase, a gene of
interest due to its potential to synthesise the signalling molecule L-
DOPA (3,4-dihydroxy-L-phenylalanine). We here describe cloning
expression and functional ratification of this molecule.
Results
Identification of a tyrosine hydroxylase with a signal
peptide sequence in T. gondii
To identify metabolic enzymes that may be secreted from T.
gondii into its host cell, we compared the enzyme set resulting from
applying the SHARKhunt search algorithm to the T. gondii
genome to the set of proteins at ToxoDB with predicted signal
peptides (www.toxodb.org (18,19). A list of 106 enzymes was
identified. Sequences with similarity to signal peptides have been
found in proteins trafficked to the parasite organelles (e.g. dense
granules, apicoplast, mitochondria) as well as secreted out of the
parasite. The known organelle proteins in the mitochondria,
apicoplast, and micronemes were removed from the list. Among
the classes of enzymes remaining, the phosphatases may be
targeted to the acidicalcisomes and UDP-N-acetylglucosamine
utilizing enzymes may be lysosomal. Several of the enzymes (six)
are involved in post-translational modification and may be
localized to the ER or Golgi apparatus. Sets of kinases and
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rhoptry, micronemal), although their specific annotation is
complicated by their membership in large gene families. Among
the remainders we focused on an unexpected metabolic enzyme
with a predicted signal peptide but no predicted transmembrane
helix; a predicted tyrosine hydroxylase. Surprisingly, there were
two hits for tyrosine hydroxylase in predicted genes in the genome
of T. gondii. Tyrosine hydroxylases have not previously been
described in protozoa but are only found in animals where they
form the rate-limiting step in synthesis of dopamine (Fig 1).
Tyrosine hydroxylase is a member of a highly conserved family of
aromatic amino acid hydroxylases consisting of tyrosine, phenyl-
alanine, and tryptophan hydroxylase. Phenylalanine hydroxylase
catabolizes phenylalanine to tyrosine and tryptophan hydroxylase
catabolizes tryptophan to 5-hydroxytryptophan. All described
aromatic amino acid hydroxylases are cytosolic and there are no
detectable signal peptide sequences (based on SignalP analysis of
GenBank entries, data not shown). Due to its presence in a
parasitic protozoan and the unique signal peptide prediction we
were interested to further characterize this enzyme.
We performed sensitive bioinformatic searches of genomes of
parasitic protozoa in the crown group alveolates whose sequences
are currently publicly available. Among the apicomplexan
genomes searched by SHARKhunt (P. falciparum, P. chabaudi, P.
berghei, C. parvum, C. hominis, B. bigemina, T. annulata, T. parva. N.
caninum, and E. tenella), the only hit for a tyrosine hydroxylase gene
or any aromatic amino acid hydroxylase was in N. caninum (E-value
of 4.0610
299) and no hits (E-value,1610
210) in any of the other
apicomplexan genomes analysed.
T. gondii contains two genes encoding tyrosine
hydroxylase
Two nearly identical genes were identified in the T. gondii
genome with similarity to metazoan tyrosine hydroxylase. They
correspond to gene models 77.m00053 and 31.m00940 in the T.
gondii genome at ToxoDB (www.toxodb.org). The sequences were
also found in EST libraries for tachyzoites and bradyzoites (www.
eupathdb.org). The two genes are located on chromosome V
separated by ,450 Kbp (kilobase pairs) with identical introns with
the exception of a few nucleotide differences in intron 7, however
the 59 and 39 UTR regions do not contain any similarity. The 59
and 39 ends of the transcript were mapped by overlapping PCR
and 39 RACE. This verified the coding sequence and placement of
the initiation and stop codons. These sequences were submitted to
GenBank as TgAaaH1 and TgAaaH2 (Toxoplasma gondii aromatic
amino acid hydroxylase) and given the identifiers EU481509 and
EU481510, respectively. The coding sequences of two genes
encode proteins of 565 residues and are 98.6% identical (Fig. 2).
The paralogous T. gondii proteins differ by eight residues in the C-
termini.
The Toxoplasma genes share high levels of similarity in the
catalytic domain to mammalian tyrosine and phenylalanine
hydroxylases. Alignment with the rat and human enzymes
(Fig. 2) reveals a clear region of similarity that begins at residue
V164 of rat tyrosine hydroxylase and V240 of the T. gondii
sequences (20). This residue denotes the beginning of the catalytic
domain with the conserved VPWFPR motif found in all tyrosine
and phenylalanine hydroxylases (21,22). The residues that interact
with the biopterin cofactor and amino acid substrates in the rat
TyrH (tyrosine hydroxylase) sequence (23) are denoted by closed
triangles in Fig. 2. The catalytic domain also contains the
conserved iron binding residues at positions His407, His412 and
Glu452 corresponding to His331, His336 and Glu376 in rat and
human tyrosine hydroxylase (24), shown highlighted with open
triangles in Fig. 2. Modelling of the structure of the T. gondii
catalytic domains on the crystal structure of rat tyrosine
hydroxylase corroborates the sequence alignment and placement
of key residues (data not shown). The N-terminal domain, which is
associated with regulation in other eukaryotic aromatic amino acid
hydroxylases, is less conserved than the catalytic domain (20). The
N-termini of the two T. gondii enzymes contains a predicted signal
peptide as expected from the original bioinformatics search (Fig. 2).
This is also found in the predicted N. caninum gene. This is the only
example of a tyrosine or phenylalanine hydroxylase with a signal
peptide. Hence, this normally cytosolic enzyme may be secreted in
this intracellular parasite.
To demonstrate activity, recombinant proteins of the two T.
gondii genes were expressed as N-terminal His-tagged fusion
proteins under control of the T7 promoter (Fig. 3). Yields of both
genes were ,0.75 mg/L culture of recombinant proteins with
,80% purity. Removal of the N-terminal signal peptide resulted
in an ,5-fold increase in the yield of soluble protein. Tyrosine,
phenylalanine and tryptophan were tested as substrates in enzyme
assays with the recombinant enzymes. There was no detectable
activity of the T. gondii enzymes with tryptophan, but the enzymes
were able to catabolize tyrosine and phenylalanine. Assays were
performed with
3H-tyrosine and
3H-phenylalanine as substrates
and the products analyzed by HPLC (Fig. 4A). A peak was
Figure 1. Schematic of the reactions catalyzed by tyrosine and phenylalanine hydroxylases. Tyrosine hydroxylase catalyzes the
conversion of tyrosine to L-DOPA and phenylalanine hydroxylase catalyzes the conversion of phenylalanine to tyrosine. Tyrosine hydroxylase is the
rate limiting step in the synthesis of the catecholamines. The tetrahydrobiopterin cofactor, essential for the activity of these enzymes, is metabolized
to 4a-hydroxytetrahydrobiopterin during the hydroxylation of the amino acid.
doi:10.1371/journal.pone.0004801.g001
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a substrate demonstrating the tyrosine hydroxylase activity. A peak
comigrating with tyrosine was observed with phenylalanine as a
substrate. This correlates with results of a coupled assay (25,26)
that shows catalysis in a dose-dependent fashion with tyrosine and
phenylalanine as substrates (Fig. 4B). The biochemical parameters
of the recombinant enzymes were measured (Table 1). The
paralogs behave similarly in all biochemical assays. The parasite
enzyme has a lower KM for tyrosine than rat tyrosine hydroxylase.
The KM for phenylalanine was 2.45–14.8 mM; considerably
higher than rat phenylalanine hydroxylase. Hence, the T. gondii
enzyme is bifunctional. Interestingly, as found for other members
of this family, the reaction is substrate-inhibited at high substrate
concentrations (Fig. 4B).
To assess the relative substrate specificity of each T. gondii
enzyme, the Vmax/Km for tyrosine and phenylalanine was
compared as in previous publications (27). We reproduced
experiments with recombinant rat tyrosine and phenylalanine
hydroxylases that demonstrate substrate specificity (20). The rat
enzymes have strict specificity, with phenylalanine having greater
than 100-fold preference for phenylalanine over tyrosine (Fig. 4C).
The T. gondii enzymes have a two to three-fold preference for
tyrosine and are therefore more similar to tyrosine hydroxylases.
In keeping with previous naming systems based on substrate
preference, the T. gondii enzyme is named a tyrosine hydroxylase.
The T. gondii enzyme differs from other tyrosine hydroxylases in its
catalytic efficiency with both substrates and is, hence, bifunctional.
Aromatic amino acid hydroxylases are dependent upon the
cofactor tetrahydrobiopterin for activity. The recombinant T.
gondii enzymes exhibited an absolute requirement for biopterin for
activity using the stable tetrahydrobiopterin analog 6-MPH4 (6-
methyl-tetrahydropterin) At concentrations ,20 mM 6-MPH4 no
catalysis was observed. A dose-response curve of activity was
obtained over a range of biopterin concentrations (Fig. 4B). The
differences in the curves for substrate and cofactor is similar to
other tyrosine hydroxylases and is likely to indicative of the
Figure 2. Alignment of aromatic amino acid hydroxylases. Aromatic amino acid hydroxylase sequences from the genes of T. gondii
(GenBank
TM accession TgAaaH1 – EU481509, TgAaaH2 – EU481510) human TyrH isoform 4 (AAA61179), rat TyrH isoform 1 (AAA42257), human PheH
(P00439) and rat PheH (AAA41843). The alignment was generated using MUSCLE alignment software [26]. Identical residues are highlighted in black.
The T. gondii proteins appear more similar to mammalian TyrH isoform 4 than isoform 1 [43]. The iron binding residues are highlighted with open
triangles. The residues present in the active site that interact with the aromatic amino acid substrate and biopterin cofactor are highlighted with black
triangles. The conserved residue implicated in substrate specificity is highlighted with an asterix; D425 encoded by rat TyrH and V379 of rat PheH.
Residues that differ between the two T. gondii proteins are highlighted with arrows. The predicted N-terminal signal peptide based on a SignalP (59)
prediction is also highlighted. The conserved VPWFPR motif identifies the start of the catalytic domain shown in brackets (61).
doi:10.1371/journal.pone.0004801.g002
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PLoS ONE | www.plosone.org 3 March 2009 | Volume 4 | Issue 3 | e4801Figure 3. T. gondii aromatic amino acid hydroxylases expressed in this study. A Schematic representation of three forms of TgAaaH 1&2
expressed in this study. Apo-TgAaaH 1&2 encode the full length wildtype protein expressed in preliminary trials as a 66His-recombinant protein of
601 amino acids (a.a.) and 66.5 kilodaltons (kDa), with the predicted signal peptide shown in black. As this protein was found to be extremely
insoluble, the N-terminal 23 codons containing the predicted signal peptide was removed generating constructs named TgAaaH 1&2. The resulting
proteins expressed are 578 a.a. and 64.1 kDa. D239TgAaaH 1&2 have the N-terminal 239 a.a. deleted resulting in expression of proteins of 361 a.a. and
40.8 kDa. B Western blot of proteins expressed from D239TgAaaH2 and TgAaaH2 and the recombinant rat protein controls probed with anti-rat
tyrosine hydroxylase. Lane 1, D239TgAaaH2, lane 2 TgAaaH2, lane 3 rat-D117PheH and lane 4 rat-WT-TyrH. Due to the high degree of similarity with
the rat enzyme, recombinant Toxoplasma proteins are recognized by antibody raised against the conserved domain of the rat tyrosine hydroxylase
enzyme. C Coomasie stained SDS-PAGE gels of purified, recombinant proteins encoded by TgAaaH1, TgAaaH2, D239TgAaaH1 and D239TgAaaH2.
doi:10.1371/journal.pone.0004801.g003
Figure 4. TgAaaH 1&2 encode tyrosine hydroxylase with unusual substrate specificity. A HPLC tracing of production of tyrosine and L-
DOPA by the recombinant enzymes. Fractions were collected and radiolabel monitored by scintillation counting. Internal markers of phenylalanine,
tyrosine, and L-DOPA are marked by arrows. B Graph showing the catalysis of tyrosine and phenylalanine in relation to substrate concentration. The
substrates are tyrosine (0–200 mM) and phenylalanine (0–200 mM). The dependency on the tetrahydrobiopterin analog 6-MPH4 over a range of
concentrations is also shown with tyrosine (50 mM) as substrate. C Relative catalysis of tyrosine and phenylalanine reveal substrate preference.
Reaction rates and KM of the substrates were measured and the ratios are shown. A ratio of 1 indicates no substrate specificity. A ratio of less than 1
indicates a preference for phenylalanine as substrate; demonstrated by the inclusion of the rat phenylalanine hydroxylase (20). A ratio of greater than
1 indicates a preference for tyrosine as demonstrated by the inclusion of rat tyrosine hydroxylase.
doi:10.1371/journal.pone.0004801.g004
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KM of 6-MPH4 for the enzymes was 310–318 mM with specific
activities of 123–137 nmol/min/mg. These are similar to the
values observed for rat tyrosine hydroxylase.
To determine the location of the catalytic domain and its
contribution to substrate specificity, deletion mutants of both genes
were generated. The N-terminal 238 residues were deleted to the
conserved VPWFPR (Fig. 2). The activity of these mutant enzymes
(D239TgAaaH1&2) was assayed for comparison to full length
enzymes. There was no loss of catalytic activity in the mutants.
The mutant enzymes had KM values for tyrosine of 3.2261.15
and 4.1260.10 mM and Vmax of 185610 and 148642 nmol/
min/mg, respectively. Hence the C-terminal sequence following
residue 239 is sufficient for catalysis. The deletion mutants were
examined to determine whether the catalytic domain also provides
the substrate specificity. The catalytic domain only mutants have
lost their preference for tyrosine (Fig. 4C). Hence the N-terminal
sequence is responsible for the tyrosine specificity.
Expression of the T. gondii hydroxylase is regulated
through development
We examined the in vivo expression of the tyrosine hydroxylase.
Initially, parasite cultures containing a mixture of tachyzoites and
bradyzoites were screened by RT-PCR with gene-specific primers
for the initiation and stop codons of TgAaaH1&2. The screen
resulted in a PCR product of the expected size and sequence
confirming the predicted coding sequence (Fig. 5A). RNA from
both genes was detectable in both life cycle stages, although these
cultures may have contained some mixture of stages. In addition,
expression of T. gondii tyrosine hydroxylase at the protein level was
confirmed by Western blotting. A single band of a 64kDa protein
was observed from tachyzoite and 6-day post pH shock bradyzoite
cultures of parasite lysate probed with tyrosine hydroxylase
antibody (Fig. 5B). Importantly, there were no bands on the gel
migrating at the size of human tyrosine hydroxylase (Mr 58.6 kD)
in the infected human foreskin fibroblasts (HFF). This was also
confirmed by RT-PCR experiments with primers directed at
human TyrH (data not shown). The high level of similarity
between the two proteins could not be distinguished by Western
blotting. The protein was principally found in the insoluble
fraction of the parasite lysate; in contrast to all other described
aromatic amino acid hydroxylases that are soluble proteins found
in the cytosol. This is consistent with the enzyme passing through
the ER and Golgi for processing prior to secretion. Immunostain-
ing of parasitized fibroblasts containing tachyzoites and brady-
zoites exhibit staining of the parasite membrane and parasito-
phorous vacuole (PV) but no visible staining of organelles
consistent with secretion (to be published elsewhere).
Gene expression of mRNA encoding TgAaaH1&2 during pH
shock induced stage conversion from the tachyzoite to the
bradyzoite life cycle stages was monitored. Steady state levels of
mRNA were measured by quantitative RT-PCR (Fig. 6 and
supplemental Data S1). Differentiation was monitored using
genetic markers (BAG1, SAG1, SAG4) (28–30) and by scoring
changes in parasitemia and number of parasites per vacuole (data
not shown). Both the avirulent type III strain NED, which forms
bradyzoites readily in culture (31) and the type I strain RH were
induced via pH shock (32). Expression of bradyzoite specific genes,
BAG1 and SAG4 increased in both strains while expression of the
tachyzoite specific gene SAG1 decreased post-induction.
TgAaaH1 mRNA was detectable in all stages whereas
TgAaaH2 expression was induced during bradyzoite differentia-
tion (Fig 6). In cultures of tachyzoites there are similar levels of
TgAaaH1 and TgAaaH2. Levels of TgAaaH2 mRNA increased
ten-fold and four-fold in NED and RH strains, respectively,
whereas the levels of TgAaaH1 mRNA remained unchanged
Table 1. Steady state kinetic parameters for tyrosine and
phenylalanine hydroxylation by T. gondii aromatic amino acid
hydroxylases.
KM(tyr) (mM)
Vmax(tyr)
(nmol/min/mg) KM(phe) (mM)
Vmax(phe)
(nmol/min/mg)
TgAaaH1 1.2560.69
a 137614
a 2.4561.87
a 125615
a
TgAaaH2 5.5063.26
a 12361
a 14.866.4
a 145637
a
Rat TyrH 1663
b 150614
b 109620
b 93612
b
Rat PheH .200
b nd
b 288659
b 373621
b
aConditions: Varied concentrations of 0–200 mM tyrosine or phenylalanine,
50 mM HEPES-NaOH, 10 mM ferrous ammonium sulphate, 500 mM NADH and
500 mM 6-MPH4 (pH 7.5 and 32uC). The error given is the SEM of two or three
separate experiments performed in duplicate or triplicate.
bData taken from (20), oxidation. The activity PheH with tyrosine is so low that
an accurate value could not be measured due to extremely low activity.
nd=not detected.
doi:10.1371/journal.pone.0004801.t001
Figure 5. Expression of T. gondii tyrosine hydroxylases in tachyzoites and bradyzoites. A 1% Agarose gel showing detection of RT-PCR
products with TgAaaH 1&2 specific primers from tachyzoites and 5 day culture induced bradyzoites from NED strain parasites. M is the DNA marker
and C is a no-template control. All products are the correct size for the ORF’s minus the introns. B Western blot of extracts of Type III NED strain
tachyzoites, induced bradyzoites (5 day) and HFF extract negative control probed with anti-rat-tyrosine hydroxylase antibody. A band of 64 kDa
corresponding to the predicted size of T. gondii tyrosine hydroxylase can be seen in both tachyzoite and bradyzoite insoluble fractions. Due to the
high level of similarity between these two proteins it was not possible to differentiate between them.
doi:10.1371/journal.pone.0004801.g005
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confirmed by recent microarray experiments (John Wooton,
personal communication). Consistent with differences in switching
in the strains, we observed a greater induction of TgAaaH2 and
bradyzoite specific genes in the avirulent type III strain than the
virulent type I strain. Therefore the parasite has increased
expression of its tyrosine hydroxylase during brain and muscle
cyst-forming stages of infection.
Discussion
In this paper, we describe the characterisation of a bifunctional
tyrosine hydroxylase from a protozoan parasite. T. gondii possesses
two nearly identical genes that exhibit very similar kinetic
properties yet differ in their developmental regulation of
expression. They may have different biological roles. Intriguingly
for a metabolic enzyme higher levels are expressed during
bradyzoite differentiation, the stage of the life cycle with low
metabolic activity. Unlike metazoan enzymes of this class, the T.
gondii enzymes are bifunctional as they are able to utilize tyrosine
and phenylalanine. Of interest, this enzyme can generate the
tyrosine for L-DOPA synthesis by metabolizing phenylalanine to
tyrosine. This was observed to some degree in experiments with
tritiated phenylalanine based on analysis by HPLC (Fig. 4A). This
gene was not found in any other apicomplexan except the closely
related N. caninum in bioinformatics searches of available genome
sequences. It is possible that this enzyme represents an unique
feature of the tissue cyst forming apicomplexan parasites.
The T. gondii tyrosine hydroxylase has two domains. The C-
terminal domain is responsible for catalysis and the N-terminal
domain determines the substrate specificity. The C-terminal
domain mutants D239TgAaaH 1&2 retained full activity. Indeed,
the vmax was slightly higher for the two deletion mutants. This is
similar to the results with other eukaryotic aromatic amino acid
hydroxylases. The two-fold and three-fold preference for tyrosine
versus phenylalanine in TgAaaH 1&2, respectively, is lost in the
N-terminal deletion mutants. The KMphe:KMtyr ratio is two fold
lower with removal of the regulatory domain whereas the
Vmax(phe):Vmax(tyr) ratio remains essentially unchanged (Fig. 4C).
The N-terminal domain greatly contributes to substrate specificity
of aromatic amino acid hydroxylases. N-terminal deletion mutants
of rat TyrH and PheH (phenylalanine hydroxylase) expressed
proteins with KM values of 0.97 and 4.33, respectively, greatly
reduced from the full length proteins (20).
Regulation of the activity of T. gondii tyrosine hydroxylase is
likely to be complex. All described eukaryotic aromatic amino acid
hydroxylases are phosphoproteins whose activity is regulated by a
series of serine-threonine kinases. There is a complex network of
phosphorylation of the N-terminal domain of eukaryotic tyrosine
hydroxylase that regulate activity in vivo. The T. gondii orthologs
have an extended N-terminal domain following the signal peptide
that contains several potential phosphorylation sites (Fig. 1). The
region is serine rich, a feature typical of phosphoproteins and T.
gondii transit peptides (33,34). There is potential for phosphoryla-
tion by host cell kinases such as those that regulate human tyrosine
hydroxylase. There is also potential for regulation by T. gondii
proteins that are released into the host including the ROP kinases
and the T. gondii 14-3-3 (35). Increased levels of host cell 14-3-3, a
well-described activator of tyrosine hydroxylase, transcripts upon
T. gondii infection have been detected, although decreased protein
levels were observed in a proteomic study (9,10,36). Definition of
the role of the N-terminal domain in regulation of the T. gondii
tyrosine hydroxylase and of the parasite and host proteins involved
awaits further experimentation.
T. gondii tyrosine hydroxylase requires the co-factor biopterin for
catalytic activity (Fig. 4B), and can therefore be classed as a
biopterin dependent aromatic amino acid hydroxylase. As
relatively few enzymes require biopterin for activity, the discovery
of a biopterin-dependent enzyme raises the issue of the possible
sources of biopterin for this enzyme. The presence or absence of a
biopterin synthetic pathway and its recycling are currently under
investigation (37,38). T. gondii has been shown to encode a
functional pterin-4a-carbinolamine dehydratase involved in recy-
cling biopterin but dihydropterin reductase has not been detected
(39). As the enzyme is secreted, the host may supply the biopterin
cofactor. Indeed, human GTP cyclohydrolase, limiting in
biopterin synthesis, has been found to be elevated in. T gondii-
infected HFF cells (10).
Figure 6. Stage specific mRNA expression of TgAaaH 1&2
during the tachyzoite to bradyzoite switch. Quantitative RT-PCR
showing stage specific mRNA expression of TgAaaH 1&2 (black bars) in
NED type III strain (A) and RH type I strain (B) parasites. Expression of
SAG1 tachyzoite specific marker and BAG 1/SAG 4 bradyzoite specific
marker genes (dashed and white bars respectively) was also followed to
confirm differentiation to bradyzoites. This analysis shown here is
relative to the housekeeping gene, GAPDH. Similar results are observed
in analysis relative to actin (shown in supplementary data). Error bars
are standard error of the mean (SEM) between flask replicates. Data was
collected from day 2–5 for the NED strain, and days 3–5 for RH as
preliminary experiments showed no change in gene expression at day 2
for RH.
doi:10.1371/journal.pone.0004801.g006
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gondii remain unclear. Expression of TgAaaH2 mRNA increases
up to ten-fold in parasites during conversion from the fast-growing
tachyzoite stage to the cyst-forming bradyzoite stage while
TgAaaH1 mRNA is unchanged (Fig. 6). Indeed, TgAaaH2
expression may be strictly stage specific as tachyzoite cultures
may contain a small proportion of bradyzoites from spontaneous
conversion, as found in previous studies (40). Assessment of
regulation at the protein level will require further experimentation
to differentiate the two gene products. The regulation may be
another example of differential expression of multiple isoenzyme
forms during stage conversion similar to enolase (41) and lactate
dehydrogenase (42), although in this case the enzyme is increased
in bradyzoites.
The amino terminus of T. gondii tyrosine hydroxylase is similar
to signal peptide motifs unlike other tyrosine and phenylalanine
hydroxylases. The sequence is conserved among the two T. gondii
tyrosine hydroxylase genes (Fig. 1). The signal peptide motif is also
conserved in the N. caninum ortholog (unpublished results). It will
be interesting to discover whether S. neurona has a similar
hydroxylase. In initial experiments, immunostaining localizes the
enzyme to the parasite membrane and parasitophorous vacuole
and there is no staining of rhoptries or dense granules (preliminary
observations). Confirmation of the PV location and the mecha-
nism of trafficking of the hydroxylase into the PV require further
experimentation.
There are several possible biological roles for a bifunctional T.
gondii tyrosine hydroxylase. It is possible that the enzyme is
required for supply of tyrosine for protein synthesis. Based on the
higher substrate selectivity for tyrosine, synthesized tyrosine will be
converted to L-DOPA (Fig. 4C). With this in mind, the question
arises what is the role of L-DOPA synthesis by T. gondii. L-DOPA is
the precursor to dopamine and increased levels of dopamine have
been detected in the brains of infected rodents (43). T. gondii infects
neuronal and glial cells and forms cysts during latent infection.
This has led to the hypothesis that increased dopamine during
infection is associated with the observed behavioural changes
(6,44,45). It is plausible that the parasite tyrosine hydroxylase is
responsible for the increased dopamine levels. Alternatively, L-
DOPA may be involved in T. gondii tissue cyst wall formation;
although the excreted oocyst of Eimeria maxima differs substantially
from tissue cysts this related coccidian parasite has been found to
contain L-DOPA in its oocyst wall glycproteins (46). L-DOPA has
also been associated with oxidative damage in cells (47). Perhaps
parasite generated L-DOPA increases reactive oxygen species
(ROS) in host cells. The reasons for T. gondii to evolve stage
specific expression of tyrosine hydroxylase remain unclear, but
finding a dual function may indicate different biological roles are
required for specific metabolic requirements in each life cycle
stage.
Materials and Methods
Parasite strains and Reagents
Toxoplasma gondii strains used; virulent type I RH-YFP strain (48)
and avirulent, cyst forming type III NED (a gift from Johan
Lindh). All chemicals were purchased from Sigma, with the
exception of 6-MPH4 from Schircks laboratories (Jona, Switzer-
land), Talon resin from Clontech and anti-tyrosine hydroxylase
monoclonal antibody from Calbiochem (San Diego, CA).
Parasite Culture
Toxoplasma gondii parasites were maintained in continuous
passage in Hs27 human foreskin fibroblast (HFF) cell monolayers
(ECACC number 94041901). Parasites were grown in DMEM
supplemented with 10% foetal bovine serum (Invitrogen, Paisley,
UK) and passaged between 4 and 15 times prior to bradyzoite
induction. Bradyzoites were induced in culture using the high
(pH 8.1) pH shock method (49). The number of parasitized cells,
vacuoles and the number of parasites per vacuole were scored
every 24 hours to monitor differentiation. Four parasitized
monolayers were harvested every 24 hours by trypsinization and
parasites purified by passage through a 21 gauge needle and
washing in phosphate-buffered saline (PBS). Parasites were
enumerated and pellets were resuspended in Qiagen RNeasy kit
RTL buffer prior to RNA extraction. For Western blotting,
parasites were harvested as in Roberts et al. (50). Proteins were
separated by SDS-PAGE, transferred onto nitrocellulose mem-
brane and probed with anti-rat-tyrosine hydroxylase monoclonal
antibody.
Prediction of the T. gondii tyrosine hydroxylase genes
The SHARKhunt search programme, part of the metaSHARK
package for automated reconstruction of metabolic pathways, was
used to predict enzymes encoded in the T. gondii genome (sequence
freely provided to the community by the Welcome Trust Sanger
Institute, Cambridge, UK and the Institute for Genomic Research
(TIGR), USA) (15–17). SHARKhunt uses HMMER profile
hidden Markov models (HMM’s) based on the PRIAM library
of polypeptide profiles (51) to search a set of DNA sequences
(finished chromosomes, contigs or expressed sequence tags) for
potential enzyme encoding genes (52). The current enzyme
collection contains 2562 profiles, covering 1967 enzymatic
functions as defined by E.C. number. Regions of DNA showing
some similarities to these profiles are analysed in detail using
GeneWise (53), which reconstructs a putative gene structure
wherever possible. Finally a confidence score in the form of an E-
value is calculated to represent the similarity between each
predicted protein product and its corresponding profile model.
Applying this software resulted in a set of genes whose sequences
were compared with sequences of predicted signal peptide
containing proteins (based on SignalP) in the T. gondii genome
resource ToxoDB providing a list of potentially secreted proteins
(www.toxodb.org, (18,19)). SHARKhunt predicted a tyrosine
hydroxylase in a reconstruction of the pathway for de novo
dopamine biosynthesis from the T. gondii genome that was
subsequently found to be encoded by two genes via ToxoDB.
These genes are mapped to different locations on chromosome V
in the T. gondii genome at ToxoDB. The genomes of the
apicomplexan parasites Neospora caninum (Wellcome Trust Sanger
Centre and the University of Liverpool), Plasmodium falciparum (54),
Plasmodium vivax (The Institute for Genomic Research), Theileria
annulata (55), Babesia bovis (56), Cryptosporidium parvum (57) and
Eimeria tenella (Wellcome Trust Sanger Centre and BBSRC
Institute for Animal Health) were also analysed for presence of
an aromatic amino acid hydroxylase.
Sequence alignments were created using Muscle multiple
alignment software (58). The signal peptide is predicted by
SignalP (59) to reside between positions 1 and 24 based on
eukaryotic networks prediction and HMM of eukaryotic models
prediction (60).
Quantitative RT-PCR
Total RNA was extracted from purified T. gondii cell pellets
using Qiagen RNeasy kit according to the manufacturers’
instructions, and cDNA synthesis performed using Superscript II
reverse transcriptase (Invitrogen). Quantity and quality of the
RNA was monitored by spectrophotometry and by gel electro-
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expression of three marker genes was also followed throughout the
experiment. These were SAG 1 (primer sequences 59-CGA-
CAGCCGCGGTCATTCTC-39 and 59-CGACAGCCGCGGT-
CATTCTC-39) (28), SAG 4, (primer sequences 59-TGGACC-
TACGATTTCAAGAAGGC-39 and 59-GCTGCGAGCTCG-
ACGGGCTCATC-39) (29) and BAG 1 (primer sequences 59-
TCCGCCGGGAGCTTGTCCACC-39 and 59-GCAAGTCAG-
CCAAAATAATCA-39) (30). Primers were designed to detect two
housekeeping genes, actin (primer sequences 59-CGAGCTGGT-
CAGTTCCTCAT-39 and 59-CATCGGGCAATTCATAG-
GAC-39) and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (primer sequences 59-GTATTGGCCGTCTGGT-
GTTC-39 and 59-CGTGGACCGAGTCGTATCTC-39) for stan-
dardization. Quantitative PCR was carried out using Abgene
SYBR green master mix (Rockford, IL) in a Bio-Rad I-cycler
(Hercules, CA) for 40 cycles. Melt curve analysis was used to
confirm the absence of primer-dimer formation or genomic DNA
(Bio-Rad I-cycler QI software version 3.0). All expression profiles
were standardised against parasite GAPDH and parasite Actin as
housekeeping genes. All primers were specific to parasite cDNA
and did not amplify HFF cDNA.
PCR amplification and open reading frame confirmation
of TgAaaH 1 & 2
cDNA from RH and NED parasites was synthesized as above.
For both genes 39 RACE was used to confirm the 39 UTR
terminus, and walking up the gene with primers confirmed the 59
transcription initiation sites (Fig. 2). The second MET codon
within the ORF (open reading frame) of TgAaaH1 is assumed to
be the translation start site due to conservation with TgAaaH2 and
a conserved predicted signal peptide. This is also found in the
predicted coding region of the N. caninum gene. PCR amplification
using primers within the 59 and 39UTR of both genes allowed
specific amplification of each transcript. Both genes were
subcloned into pGEM-T Easy vector (Promega, Madison, WI)
for sequencing. There were no coding differences between the RH
and NED genes.
Expression and purification of recombinant proteins
Restriction sites for Pst I and Not 1 were added to the termini of
both full length ORFs by PCR using Phusion polymerase
(Invitrogen) from the pGEM-T constructs. Primers were: forward
primer 59-CTGCAGATGTGGCAGGCCATTTTCGCTG-39,
reverse primer (TgAaaH1) 59-GCGGCCGCTAGAACCT-
GAGGGAAACGGG-39 and reverse primer (TgAaaH2) 59-
GCGGCCGCTAGATCTTGAGGGAGACGGG-39. The PCR
products were again sub-cloned into pGEM-T easy vector
(Promega), digested with Pst I and Not I restriction enzymes and
inserted into pET 45b expression vector (Novagen, Madison, WI)
with Promega ligase. Vectors containing the correct insert were
confirmed by sequencing and double digest with Pst I/Not I and
with Bam HI only. These constructs were named Apo-TgAaaH1
and Apo-TgAaaH2.
Deletion constructs were generated by PCR with Phusion
polymerase using primers beginning at residue 23 (59-
GGTTCTGCAGGCTGTCCCCCAAGAATC-39) to residue
239 (59-CTGCAGGTCCCGTGGTTCCCTCGGTCT-39) from
both TgAaaH 1 and TgAaaH2 cloned in pGEM-T plasmids,
generating a terminal Pst1 site and an in-frame start codon. The
PCR products were cloned into pGEM-T easy before sub-cloning
into pET 45b as above. Deletion of the first 23 residues removed
the region predicted to be a signal peptide (Fig. 2), these were then
referred to as TgAaaH 1&2. Deletion of the first 239 residues
results in constructs beginning at the VPWFPR motif at the start of
the putative catalytic domain (20, 61, 62), these were then named
D239TgAaaH 1 & 2. All constructs were sequenced in pET 45b
prior to expression (Fig. 3).
All pET 45b constructs were transformed by electroporation
into BL21 GOLD (DE3) pLysS E. coli (Novagen). Cultures were
grown for ,4 hrs at 37uC in TB media supplemented with 10 mM
ferrous ammonium sulphate to an OD600 of ,0.8, induced with
0.1 mM IPTG and shaken for 20 hrs at 18uC (TgAaaH) or 28uC
(D239TgAaaH). Cultures were harvested by centrifugation at
10,0006g for 5 min and pellets stored at 270uC overnight. All cell
pellets were resuspended in 50 mM Tris-HCL pH 7.5, plus 0.2%
Triton-X 100 and EDTA-free protease inhibitors (Roche, Nutley,
NJ). These were sonicated for 30 sec with 30 sec rest three times
on ice. Extracts were spun at 20,0006g for 20 min at 4uC and the
soluble fraction removed. This was repeated two times with ten
cycles of 30 s sonication/30 s rest on ice. The resulting soluble
fraction was passed over a Talon affinity resin column (Clontech)
and eluted with 500 mM imidazole. The imidazole was removed
by dialysis for 2 hrs at 4uC against 50 mM Tris-HCL pH 7.5, plus
0.2% Triton-X100. Coomasie-stained SDS-PAGE electrophoresis
and Western blotting with anti-rat-tyrosine hydroxylase monoclo-
nal antibody and anti-His-tag antibody assessed the purity of each
protein. As tyrosine hydroxylases contain an iron atom embedded
in the structure that is required for catalytic activity, we increased
the Fe
2+ concentration of the expression media by the addition of
ferrous ammonium sulphate to ensure that all the recombinant
enzyme would contain Fe
2+ (63–65). The additional iron increased
the percentage of soluble protein suggesting that the presence of
the central iron atom may be required for correct folding in this
expression system. The addition of 0.2% Triton-X 100 and low
salt concentrations also enhanced the solubility as seen with
previous recombinant tyrosine hydroxylase enzymes (66).
Constructs for the expression of rat tyrosine hydroxylase (rat-
WT-TyrH) and the catalytic domain of rat phenylalanine
hydroxylase (rat-D117PheH) in pET 23d, were a kind gift from
Paul Fitzpatrick. Both proteins were expressed without a tag and
enriched by step-wise ammonium sulphate precipitation (61).
Biochemical assays
Assays were developed and standardized using recombinant
proteins from expression of rat-WT-TyrH and rat-D117PheH.
Protein concentration was determined using the Bradford assay
(67). All assays were initiated by the addition of 10 mg enzyme. As
the reproducibility of biopterin-dependent enzyme kinetics are
greatly affected by the instability of the biopterin cofactor, 6-
MPH4 was used and checked prior to assay by assessing the 240–
300 nm spectrum. Assays were 10 min as biopterins are unstable
in air and prolonged incubation with BH4 ((6R)-tetrahydropterin)
will inactivate these enzymes (68, 69). The hydroxylation of
tyrosine was measured by the method of Fitzpatrick (25) with the
modifications of Royo et al. (26). Conditions were 25uC, pH 7.5,
10 mM HEPES, 1 mM DTT, 100 mg/ml catalase and 10 mM
ferrous ammonium sulphate. Assays were terminated at 10 min by
the addition of 15 ml 50% HCL, 200 ml 12.5% sodium nitrite and
200 ml 12.5%. NaOH (70 ml 3 M) was then added to each
reaction and the absorbance at 500 nm read precisely 10 sec later.
All assays were initiated by the addition of the enzyme.
Additionally, the hydroxylation of phenylalanine was assayed by
direct measurement of the production of tyrosine at 275 nm
according to the method of Pember et al. (70) with the
modifications of Daubner et al. (71). Conditions were 25uC,
pH 7.5, 80 mM HEPES, 5 mM DTT, 60 mg/ml catalase and
10 mM ferrous ammonium sulphate. Tyrosine and dopa production
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[2,3,4,5,6-
3H]phenylalanine (25 mCi; final chemical concentration
1 mM) or 25 mCi L-[2,3,5,6-
3H]tyrosine (final chemical concentra-
tion 1.25 mM) (GE Healthcare) was added to 10 mg recombinant
protein in 200 ml reaction volumes. Reaction conditions were
500 mM 6-MPH4, 50 mM HEPES, 20% glycerol, 0.25% Triton-X
100 and EDTA free protease inhibitors (Roche) at pH 7.5.
Reactions were initiated by the addition of enzyme and allowed
to proceed for 4 hrs at 37uC. Reactions were stopped by freezing in
liquid nitrogen and stored at 280uC prior to HPLC analysis.
In preparation for HPLC 50 ml of each assay mix was added to
210 ml 0.1% TFA (trifluroacetic acid). To this was added 5 mlo f
1 mg/ml dopa, tyrosine and phenylalanine as standards. Samples
were spun at 130006g in a bench top microfuge to pellet the
precipitated protein. Products were separated by reverse phase
HPLC on a Synergi 4u Hydro 80A column (15064.60 mm,
Phenomenex, Macclesfield, UK) with an elution gradient of 0–
60% acetonitrile with 0.1% TFA over 20 min at a flow rate of
1 ml/min. Fractions (0.5 ml) were collected every 30 sec from
6 min-18 min for each sample. Each fraction was counted for
1 min in 3 ml liquid scintillant (Packcard, Minnesota, USA) on a
Wallac 1450 Microbeta Trilux counter using default settings.
For kinetic calculations an assay measuring the oxidation of 6-
MPH4 using a coupled reaction measuring the decrease in
absorbance at 340 nm due to NADH oxidation (61) was used as
this assay has been validated for use in several previous studies
(20,25,66). Conditions were 32uC, pH 7.5, 10 mg purified protein,
50 mM HEPES, 100 mg/ml catalase, 500 mM NADH, 10 mM
ferrous ammonium sulphate, 0.2 u/ml sheep liver dihydropter-
idine reductase. For KmTyr/KmPhe measurements concentrations
of amino acids were varied from 0–200 mM with 500 mM6 -
MPH4. For Km6-MPH4 concentrations of 6-MPH4 were varied
from 0–500 mM with 50 mM of each amino acid separately.
Data analysis
Kinetic data was fitted to the Michaelis-Menten equation using
Graphpad PRISM (San Diego, California).
Supporting Information
Data S1 Supplemental Data S1. Stage specific mRNA expres-
sion of TgAaaH 1&2 during the tachyzoite to bradyzoite switch
against actin as a housekeeping gene. Quantitative RT-PCR
showing stage specific mRNA expression of TgAaaH 1&2 (black
bars) in NED type III strain (A) and RH type I strain (B) parasites.
Expression of SAG1 tachyzoite specific marker and BAG 1/SAG
4 bradyzoite specific marker genes (dashed and white bars
respectively) was also followed to confirm differentiation to
bradyzoites. The analysis shown here is relative to actin as a
housekeeping control gene. Error bars are error between flask
replicates. Data was collected from day 2–5 for the NED strain,
and days 3–5 for RH as preliminary experiments showed no
change in gene expression at day 2 for RH.
Found at: doi:10.1371/journal.pone.0004801.s001 (22.42 MB
TIF)
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